Explore how CAR-T cell therapy is revolutionizing cancer treatment by reprogramming the body's own immune cells to target and destroy cancer.
Explore how retroviral vectors and TCR transgenic mice revolutionize immune cell engineering for cancer immunotherapy and disease research.
Exploring how tumor aneuploidy drives immune evasion and reduces response to immunotherapy, with clinical insights and future therapeutic strategies.